An updated review on the diagnosis and assessment of post-treatment relapse in brain metastases using PET-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An updated review on the diagnosis and assessment of post-treatment relapse in brain metastases using PET

Published:2022-11-02 Issue:11-12 Volume:22 Page:915-921
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Galldiks Norbert¹²³,Wollring Michael¹²,Werner Jan-Michael¹,Friedrich Michel²,Fink Gereon R.¹²,Langen Karl-Josef²³⁴,Lohmann Philipp²⁵

Affiliation:

1. Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany

2. Inst. of Neuroscience and Medicine (INM-3, −4), Research Center Juelich, Germany

3. Center for Integrated Oncology (CIO), Universities of Aachen, Bonn, Germany

4. Department of Nuclear Medicine, University Hospital RWTH Aachen, Germany

5. Department of Stereotaxy and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

Funder

This paper was supported by funds from the Deutsche Forschungsgemeinschaft

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737175.2022.2162880

Reference62 articles.

1. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours

2. Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

3. Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study

4. Advances in neuro-oncology imaging

5. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Applications of Radiomics in Nuclear Medicine;Nuklearmedizin - NuclearMedicine;2023-11-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3